<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01402375</url>
  </required_header>
  <id_info>
    <org_study_id>11-02-066</org_study_id>
    <nct_id>NCT01402375</nct_id>
  </id_info>
  <brief_title>Comparing the Efficacy of Oral Opioids for Outpatient Acute Pain Management After ED Discharge Discharge</brief_title>
  <official_title>Comparing the Efficacy of Oral Opioids for Outpatient Acute Pain Management After ED Discharge</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There will be 3 randomized, double-blinded clinical trials to help determine which of
      commonly prescribed oral opioid combination is most effective in managing acute extremity
      pain after discharge from the adult emergency department. The first trial compares
      hydrocodone 5mg / acetaminophen 500mg to codeine 30mg/acetaminophen 300mg. The second trial
      compares oxycodone 5mg/acetaminophen 325mg to codeine 30mg/acetaminophen 300mg. The third
      trial compares oxycodone 5mg/acetaminophen 325 mg to hydrocodone 5mg/acetaminophen 325 mg.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible patients are those between the ages of 21 and 64 who present to the Emergency
      Department (ED) with a complaint of acute extremity pain of less than seven days duration in
      one or more extremities and for whom the clinician plans to discharge on an oral opioid for
      pain management. Patients will be excluded if they have ever taken methadone; have a chronic
      condition requiring frequent pain management such as sickle cell disease, fibromyalgia, or
      any neuropathy; report a history of an adverse reaction to any of the study medications; if
      they have taken prescribed opioids in the past 24 hours or if they report having ever taken
      recreational narcotics; if they have a medical condition that might affect their metabolism
      of opioid analgesics or acetaminophen; or if they take any medicine that might interact with
      one of the study medications. Patients will be referred by the attending physician or
      clinician and consent as well as the initial and follow-up data collections will be obtained
      by our team of trained bilingual (Spanish and English) salaried research associates who staff
      the ED 24 hours a day and 7 days a week.

      In the first study, patients will be randomized to one of two experimental groups:
      hydrocodone 5mg / acetaminophen 500mg or codeine 30mg / acetaminophen 300mg. Randomization
      will be performed in blocks of 10 and determined by a sequence generated at
      http://www.randomization.com. The pharmacist working in an area inaccessible to ED staff will
      ensure proper blinding of the study by masking the medication and inserting it into unmarked
      gel capsules and filling any void with small amounts of lactose. A three-day supply (18
      doses) of the blinded medications will be dispensed by the ED staff to the patient in the
      order determined by randomization accompanied by instructions to use one tablet of the
      medication every 4 hours as needed for pain and to avoid use of any other analgesics.

      Using a power of 80%, a significance criterion of 0.5, and an estimated delta of 1.3 NRS
      units, a sample size of 85 patients per group. In order to account for those that do not end
      up taking the medicine, it is estimated that 120 patients per group will have to be enrolled.

      Data will be collected on a standardized data collection instrument, entered by a trained
      data clerk, and reviewed and audited for accuracy and completeness. The investigators will
      calculate descriptive statistics for all variables: frequencies, means and standard
      deviations, medians and IQR, and proportions. Chi-square tests will be used to test
      differences between dichotomous variables, t-tests will be used to test mean differences.
      Multivariate models will be used if there are background variables that are unevenly
      distributed between the two groups. Variables associated with group membership with
      probability of 0.20 or less will be included in OLS multivariate regression or logistic
      regression models in order to test the role of group membership while accounting for chance
      baseline disparities. Interaction terms will be tested and dropped from the models if they
      were not statically significant at the 0.05 level. SPSS version 17 (Chicago, IL.) will be
      used to conduct all data analyses.

      The second trial will be identical to the first trial with the exception of one of the study
      drugs, which will be oxycodone 5mg / acetaminophen 325 mg which will be compared to codeine
      30mg / acetaminophen 300mg.

      The third trial will be identical to the first and second trials with the exception of study
      drugs. This study will use oxycodone 5 mg/acetaminophen 325mg and hydrocodone
      5mg/acetaminophen 325mg.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2012</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Pain Intensity Score Before and After Last Dose.</measure>
    <time_frame>2 hrs</time_frame>
    <description>Pain intensity is measured on the numerical rating scale (NRS) from 0 (&quot;no pain&quot;) to 10 (&quot;worst pain imaginable&quot;). The difference in pain score is calculated by subtracting the average score 2 hours after pain medication is taken from the average pain score immediately before the pain medication is taken.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Satisfaction With the Pain Medicine</measure>
    <time_frame>24 hrs</time_frame>
    <description>Overall satisfaction with the oral opioid pain medication at 24 hours after discharge using a Likert scale. Patients will be asked to describe their overall experience as being very satisfied, satisfied, unsatisfied or very unsatisfied with the study medication.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">720</enrollment>
  <condition>Analgesia After ED Discharge for Extremity Injuries</condition>
  <arm_group>
    <arm_group_label>Hydrocodone (first trial)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydrocodone 5mg / Acetaminophen 500mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Codeine (first trial)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone (for second trial)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxycodone 5mg / Acetaminophen 325mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Codeine (for second trial)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone (third trial)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxycodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrocodone (third trial)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydrocodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocodone (first trial)</intervention_name>
    <description>Patients will take 1 dose of Hydrocodone 5mg / Acetaminophen 500mg every 4 hours as needed for pain</description>
    <arm_group_label>Hydrocodone (first trial)</arm_group_label>
    <other_name>Vicodin (Hydrocodone 5mg / Acetaminophen 500mg)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Codeine (first trial)</intervention_name>
    <description>Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
    <arm_group_label>Codeine (first trial)</arm_group_label>
    <other_name>Tylenol # 3 (Codeine 30 mg/Acetaminophen 300 mg)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone (for second trial)</intervention_name>
    <description>Patients will take 1 dose of Oxycodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
    <arm_group_label>Oxycodone (for second trial)</arm_group_label>
    <other_name>Percocet (Oxycodone 5mg/Acetaminophen 325 mg)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Codeine (for second trial)</intervention_name>
    <description>Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
    <arm_group_label>Codeine (for second trial)</arm_group_label>
    <other_name>Tylenol # 3 (Codeine 30 mg/Acetaminophen 300 mg)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone (third trial)</intervention_name>
    <description>Patients will take 1 dose of Oxycodone 5mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
    <arm_group_label>Oxycodone (third trial)</arm_group_label>
    <other_name>Oxycodone 5mg / Acetaminophen 325 mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocodone (third trial)</intervention_name>
    <description>Patients will take 1 dose of Hydrocodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain.</description>
    <arm_group_label>Hydrocodone (third trial)</arm_group_label>
    <other_name>Hydrocodone 5mg / Acetaminophen 325 mg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient has complaint of acute extremity pain (less than 7 days duration)

          -  clinician plans to discharge on oral pain medication

        Exclusion Criteria:

          -  patients on methadone

          -  chronic pain condition such as sickle cell anemia or fibromyalgia

          -  history of adverse reaction to one of the study medications

          -  taken prescribed opioids in the past 24 hrs

          -  have a medical condition that might alter the metabolism of one of the study
             medications (i.e. hepatitis, renal insufficiency, thyroid disease, Adrenal disease)

          -  Take a medication that might interact with one of the study medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Chang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2011</study_first_submitted>
  <study_first_submitted_qc>July 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2011</study_first_posted>
  <results_first_submitted>March 1, 2018</results_first_submitted>
  <results_first_submitted_qc>April 27, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">May 1, 2018</results_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Andrew Chang, MD</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Pain Management</keyword>
  <keyword>Emergency Medicine</keyword>
  <keyword>Extremity Injuries</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Hydrocodone (First Trial)</title>
          <description>Hydrocodone 5mg / Acetaminophen 500mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Hydrocodone (first trial): Patients will take 1 dose of Hydrocodone 5mg / Acetaminophen 500mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="P2">
          <title>Codeine (First Trial)</title>
          <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (first trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="P3">
          <title>Oxycodone (for Second Trial)</title>
          <description>Oxycodone 5mg / Acetaminophen 325mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Oxycodone (for second trial): Patients will take 1 dose of Oxycodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="P4">
          <title>Codeine (for Second Trial)</title>
          <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (for second trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="P5">
          <title>Oxycodone (Third Trial)</title>
          <description>Oxycodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Oxycodone (third trial): Patients will take 1 dose of Oxycodone 5mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="P6">
          <title>Hydrocodone (Third Trial)</title>
          <description>Hydrocodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Hydrocodone (third trial): Patients will take 1 dose of Hydrocodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
                <participants group_id="P2" count="120"/>
                <participants group_id="P3" count="120"/>
                <participants group_id="P4" count="120"/>
                <participants group_id="P5" count="120"/>
                <participants group_id="P6" count="120"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
                <participants group_id="P2" count="120"/>
                <participants group_id="P3" count="120"/>
                <participants group_id="P4" count="120"/>
                <participants group_id="P5" count="120"/>
                <participants group_id="P6" count="120"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Patients excluded from data analysis:
First trial - patients did not take study medication Second trial - 7 patients unable to be reached for follow up, 18 did not take study medication Third trial - 5 patients unable to be reached for follow up, 15 did not take study medication</population>
      <group_list>
        <group group_id="B1">
          <title>Hydrocodone (First Trial)</title>
          <description>Hydrocodone 5mg / Acetaminophen 500mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Hydrocodone (first trial): Patients will take 1 dose of Hydrocodone 5mg / Acetaminophen 500mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="B2">
          <title>Codeine (First Trial)</title>
          <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (first trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="B3">
          <title>Oxycodone (for Second Trial)</title>
          <description>Oxycodone 5mg / Acetaminophen 325mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Oxycodone (for second trial): Patients will take 1 dose of Oxycodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="B4">
          <title>Codeine (for Second Trial)</title>
          <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (for second trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="B5">
          <title>Oxycodone (Third Trial)</title>
          <description>Oxycodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Oxycodone (third trial): Patients will take 1 dose of Oxycodone 5mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="B6">
          <title>Hydrocodone (Third Trial)</title>
          <description>Hydrocodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Hydrocodone (third trial): Patients will take 1 dose of Hydrocodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain.</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="88"/>
            <count group_id="B2" value="93"/>
            <count group_id="B3" value="111"/>
            <count group_id="B4" value="104"/>
            <count group_id="B5" value="107"/>
            <count group_id="B6" value="113"/>
            <count group_id="B7" value="616"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34" spread="12"/>
                    <measurement group_id="B2" value="37" spread="11"/>
                    <measurement group_id="B3" value="39" spread="12"/>
                    <measurement group_id="B4" value="38" spread="11"/>
                    <measurement group_id="B5" value="39" spread="12"/>
                    <measurement group_id="B6" value="38" spread="13"/>
                    <measurement group_id="B7" value="38" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="58"/>
                    <measurement group_id="B5" value="60"/>
                    <measurement group_id="B6" value="48"/>
                    <measurement group_id="B7" value="314"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="49"/>
                    <measurement group_id="B4" value="46"/>
                    <measurement group_id="B5" value="47"/>
                    <measurement group_id="B6" value="65"/>
                    <measurement group_id="B7" value="302"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="66"/>
                    <measurement group_id="B4" value="71"/>
                    <measurement group_id="B5" value="67"/>
                    <measurement group_id="B6" value="73"/>
                    <measurement group_id="B7" value="402"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="27"/>
                    <measurement group_id="B5" value="32"/>
                    <measurement group_id="B6" value="28"/>
                    <measurement group_id="B7" value="167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="12"/>
                    <measurement group_id="B7" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="88"/>
                    <measurement group_id="B2" value="93"/>
                    <measurement group_id="B3" value="111"/>
                    <measurement group_id="B4" value="104"/>
                    <measurement group_id="B5" value="107"/>
                    <measurement group_id="B6" value="113"/>
                    <measurement group_id="B7" value="616"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NRS pain intensity score on ED arrival</title>
          <description>Pain intensity is measured on the numerical rating scale (NRS) from 0 (&quot;no pain&quot;) to 10 (&quot;worst pain imaginable&quot;)</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9" lower_limit="8" upper_limit="10"/>
                    <measurement group_id="B2" value="9" lower_limit="8" upper_limit="10"/>
                    <measurement group_id="B3" value="10" lower_limit="8" upper_limit="10"/>
                    <measurement group_id="B4" value="10" lower_limit="8" upper_limit="10"/>
                    <measurement group_id="B5" value="10" lower_limit="8" upper_limit="10"/>
                    <measurement group_id="B6" value="10" lower_limit="8" upper_limit="10"/>
                    <measurement group_id="B7" value="10" lower_limit="8" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NRS pain intensity score on discharge</title>
          <description>Pain intensity is measured on the numerical rating scale (NRS) from 0 (&quot;no pain&quot;) to 10 (&quot;worst pain imaginable&quot;).
The study involved patients taking study medications AFTER emergency department discharge, and the primary outcome also involved NRS pain scores 24 hours AFTER ED discharge. Thus, any data collected while in the ED is considered baseline.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7" lower_limit="5" upper_limit="8"/>
                    <measurement group_id="B2" value="7" lower_limit="5" upper_limit="8"/>
                    <measurement group_id="B3" value="7" lower_limit="6" upper_limit="9"/>
                    <measurement group_id="B4" value="7" lower_limit="5" upper_limit="9"/>
                    <measurement group_id="B5" value="8" lower_limit="6" upper_limit="9"/>
                    <measurement group_id="B6" value="8" lower_limit="6" upper_limit="9"/>
                    <measurement group_id="B7" value="7" lower_limit="5" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diagnosis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Sprain/strain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="59"/>
                    <measurement group_id="B4" value="49"/>
                    <measurement group_id="B5" value="39"/>
                    <measurement group_id="B6" value="42"/>
                    <measurement group_id="B7" value="283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Extremity Fracture</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="37"/>
                    <measurement group_id="B5" value="63"/>
                    <measurement group_id="B6" value="58"/>
                    <measurement group_id="B7" value="228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="13"/>
                    <measurement group_id="B7" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Took analgesic prior to presentation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="72"/>
                    <measurement group_id="B4" value="70"/>
                    <measurement group_id="B5" value="76"/>
                    <measurement group_id="B6" value="74"/>
                    <measurement group_id="B7" value="418"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="33"/>
                    <measurement group_id="B5" value="29"/>
                    <measurement group_id="B6" value="36"/>
                    <measurement group_id="B7" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Difference in Pain Intensity Score Before and After Last Dose.</title>
        <description>Pain intensity is measured on the numerical rating scale (NRS) from 0 (&quot;no pain&quot;) to 10 (&quot;worst pain imaginable&quot;). The difference in pain score is calculated by subtracting the average score 2 hours after pain medication is taken from the average pain score immediately before the pain medication is taken.</description>
        <time_frame>2 hrs</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hydrocodone (First Trial)</title>
            <description>Hydrocodone 5mg / Acetaminophen 500mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Hydrocodone (first trial): Patients will take 1 dose of Hydrocodone 5mg / Acetaminophen 500mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O2">
            <title>Codeine (First Trial)</title>
            <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (first trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone (for Second Trial)</title>
            <description>Oxycodone 5mg / Acetaminophen 325mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Oxycodone (for second trial): Patients will take 1 dose of Oxycodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O4">
            <title>Codeine (for Second Trial)</title>
            <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (for second trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O5">
            <title>Oxycodone (Third Trial)</title>
            <description>Oxycodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Oxycodone (third trial): Patients will take 1 dose of Oxycodone 5mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O6">
            <title>Hydrocodone (Third Trial)</title>
            <description>Hydrocodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Hydrocodone (third trial): Patients will take 1 dose of Hydrocodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Pain Intensity Score Before and After Last Dose.</title>
          <description>Pain intensity is measured on the numerical rating scale (NRS) from 0 (&quot;no pain&quot;) to 10 (&quot;worst pain imaginable&quot;). The difference in pain score is calculated by subtracting the average score 2 hours after pain medication is taken from the average pain score immediately before the pain medication is taken.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="88"/>
                <count group_id="O2" value="93"/>
                <count group_id="O3" value="111"/>
                <count group_id="O4" value="104"/>
                <count group_id="O5" value="107"/>
                <count group_id="O6" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>before most recent dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.6" spread="1.7"/>
                    <measurement group_id="O2" value="7.6" spread="1.8"/>
                    <measurement group_id="O3" value="7.9" spread="1.5"/>
                    <measurement group_id="O4" value="7.9" spread="1.7"/>
                    <measurement group_id="O5" value="7.8" spread="1.5"/>
                    <measurement group_id="O6" value="7.6" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours after most recent dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="2.8"/>
                    <measurement group_id="O2" value="4.1" spread="2.9"/>
                    <measurement group_id="O3" value="3.4" spread="2.5"/>
                    <measurement group_id="O4" value="3.6" spread="4.2"/>
                    <measurement group_id="O5" value="3.3" spread="2.7"/>
                    <measurement group_id="O6" value="3.6" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>change in NRS before to after most recent dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="2.5"/>
                    <measurement group_id="O2" value="3.5" spread="2.6"/>
                    <measurement group_id="O3" value="4.5" spread="2.4"/>
                    <measurement group_id="O4" value="4.2" spread="2.4"/>
                    <measurement group_id="O5" value="4.4" spread="2.5"/>
                    <measurement group_id="O6" value="4.0" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Satisfaction With the Pain Medicine</title>
        <description>Overall satisfaction with the oral opioid pain medication at 24 hours after discharge using a Likert scale. Patients will be asked to describe their overall experience as being very satisfied, satisfied, unsatisfied or very unsatisfied with the study medication.</description>
        <time_frame>24 hrs</time_frame>
        <population>Any number analyzed that does not equal the overall number of participants is due to missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Hydrocodone (First Trial)</title>
            <description>Hydrocodone 5mg / Acetaminophen 500mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Hydrocodone (first trial): Patients will take 1 dose of Hydrocodone 5mg / Acetaminophen 500mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O2">
            <title>Codeine (First Trial)</title>
            <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (first trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone (for Second Trial)</title>
            <description>Oxycodone 5mg / Acetaminophen 325mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Oxycodone (for second trial): Patients will take 1 dose of Oxycodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O4">
            <title>Codeine (for Second Trial)</title>
            <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (for second trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O5">
            <title>Oxycodone (Third Trial)</title>
            <description>Oxycodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Oxycodone (third trial): Patients will take 1 dose of Oxycodone 5mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O6">
            <title>Hydrocodone (Third Trial)</title>
            <description>Hydrocodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Hydrocodone (third trial): Patients will take 1 dose of Hydrocodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Satisfaction With the Pain Medicine</title>
          <description>Overall satisfaction with the oral opioid pain medication at 24 hours after discharge using a Likert scale. Patients will be asked to describe their overall experience as being very satisfied, satisfied, unsatisfied or very unsatisfied with the study medication.</description>
          <population>Any number analyzed that does not equal the overall number of participants is due to missing data</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="88"/>
                <count group_id="O2" value="93"/>
                <count group_id="O3" value="111"/>
                <count group_id="O4" value="104"/>
                <count group_id="O5" value="107"/>
                <count group_id="O6" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of participants satisfied with analgesic</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="87"/>
                    <count group_id="O2" value="93"/>
                    <count group_id="O3" value="111"/>
                    <count group_id="O4" value="104"/>
                    <count group_id="O5" value="107"/>
                    <count group_id="O6" value="113"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="66"/>
                    <measurement group_id="O3" value="99"/>
                    <measurement group_id="O4" value="91"/>
                    <measurement group_id="O5" value="93"/>
                    <measurement group_id="O6" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>participants would want the same analgesic again</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="85"/>
                    <count group_id="O2" value="93"/>
                    <count group_id="O3" value="111"/>
                    <count group_id="O4" value="104"/>
                    <count group_id="O5" value="107"/>
                    <count group_id="O6" value="113"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="66"/>
                    <measurement group_id="O3" value="91"/>
                    <measurement group_id="O4" value="85"/>
                    <measurement group_id="O5" value="86"/>
                    <measurement group_id="O6" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>50% or Greater Decrease in Numerical Rating Scale (NRS) Pain Score</title>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hydrocodone (First Trial)</title>
            <description>Hydrocodone 5mg / Acetaminophen 500mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Hydrocodone (first trial): Patients will take 1 dose of Hydrocodone 5mg / Acetaminophen 500mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O2">
            <title>Codeine (First Trial)</title>
            <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (first trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone (for Second Trial)</title>
            <description>Oxycodone 5mg / Acetaminophen 325mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Oxycodone (for second trial): Patients will take 1 dose of Oxycodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O4">
            <title>Codeine (for Second Trial)</title>
            <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (for second trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O5">
            <title>Oxycodone (Third Trial)</title>
            <description>Oxycodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Oxycodone (third trial): Patients will take 1 dose of Oxycodone 5mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O6">
            <title>Hydrocodone (Third Trial)</title>
            <description>Hydrocodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Hydrocodone (third trial): Patients will take 1 dose of Hydrocodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain.</description>
          </group>
        </group_list>
        <measure>
          <title>50% or Greater Decrease in Numerical Rating Scale (NRS) Pain Score</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="88"/>
                <count group_id="O2" value="93"/>
                <count group_id="O3" value="111"/>
                <count group_id="O4" value="104"/>
                <count group_id="O5" value="107"/>
                <count group_id="O6" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="45"/>
                    <measurement group_id="O3" value="73"/>
                    <measurement group_id="O4" value="64"/>
                    <measurement group_id="O5" value="68"/>
                    <measurement group_id="O6" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Time to Follow up</title>
        <description>Median time to contact patients for data collection, measured from discharge to time contacted</description>
        <time_frame>up to 48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hydrocodone (First Trial)</title>
            <description>Hydrocodone 5mg / Acetaminophen 500mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Hydrocodone (first trial): Patients will take 1 dose of Hydrocodone 5mg / Acetaminophen 500mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O2">
            <title>Codeine (First Trial)</title>
            <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (first trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O3">
            <title>Oxycodone (for Second Trial)</title>
            <description>Oxycodone 5mg / Acetaminophen 325mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Oxycodone (for second trial): Patients will take 1 dose of Oxycodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O4">
            <title>Codeine (for Second Trial)</title>
            <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (for second trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O5">
            <title>Oxycodone (Third Trial)</title>
            <description>Oxycodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Oxycodone (third trial): Patients will take 1 dose of Oxycodone 5mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
          </group>
          <group group_id="O6">
            <title>Hydrocodone (Third Trial)</title>
            <description>Hydrocodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Hydrocodone (third trial): Patients will take 1 dose of Hydrocodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Follow up</title>
          <description>Median time to contact patients for data collection, measured from discharge to time contacted</description>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="88"/>
                <count group_id="O2" value="93"/>
                <count group_id="O3" value="111"/>
                <count group_id="O4" value="104"/>
                <count group_id="O5" value="107"/>
                <count group_id="O6" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" lower_limit="24" upper_limit="42"/>
                    <measurement group_id="O2" value="25" lower_limit="24" upper_limit="36"/>
                    <measurement group_id="O3" value="26" lower_limit="24" upper_limit="37"/>
                    <measurement group_id="O4" value="28" lower_limit="25" upper_limit="36"/>
                    <measurement group_id="O5" value="27" lower_limit="25" upper_limit="42"/>
                    <measurement group_id="O6" value="28" lower_limit="25" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>follow up period, 24-48 hours</time_frame>
      <desc>In adverse events, any change in total participants at risk from overall number reflects missing data</desc>
      <group_list>
        <group group_id="E1">
          <title>Hydrocodone (First Trial)</title>
          <description>Hydrocodone 5mg / Acetaminophen 500mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Hydrocodone (first trial): Patients will take 1 dose of Hydrocodone 5mg / Acetaminophen 500mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="E2">
          <title>Codeine (First Trial)</title>
          <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (first trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="E3">
          <title>Oxycodone (for Second Trial)</title>
          <description>Oxycodone 5mg / Acetaminophen 325mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Oxycodone (for second trial): Patients will take 1 dose of Oxycodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="E4">
          <title>Codeine (for Second Trial)</title>
          <description>Codeine 30mg / Acetaminophen 300mg. Patients instructed to take 1 dose every 4 hrs as needed for pain.
Codeine (for second trial): Patients will take 1 dose of Codeine 30 mg / Acetaminophen 300 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="E5">
          <title>Oxycodone (Third Trial)</title>
          <description>Oxycodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Oxycodone (third trial): Patients will take 1 dose of Oxycodone 5mg / Acetaminophen 325 mg every 4 hours as needed for pain</description>
        </group>
        <group group_id="E6">
          <title>Hydrocodone (Third Trial)</title>
          <description>Hydrocodone 5mg / Acetaminophen 325 mg. Patients instructed to take 1 dose every 4 hours as needed for pain.
Hydrocodone (third trial): Patients will take 1 dose of Hydrocodone 5 mg / Acetaminophen 325 mg every 4 hours as needed for pain.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="88"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="93"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="107"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="113"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="88"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="93"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="107"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="113"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="88"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="93"/>
                <counts group_id="E3" subjects_affected="68" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="61" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="74" subjects_at_risk="106"/>
                <counts group_id="E6" subjects_affected="51" subjects_at_risk="112"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="87"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="92"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="18" subjects_at_risk="105"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="112"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="87"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="92"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="105"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="112"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="88"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="93"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="110"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="93"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="106"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="110"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="87"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="93"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="18" subjects_at_risk="106"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="111"/>
              </event>
              <event>
                <sub_title>Drowsiness</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="88"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="93"/>
                <counts group_id="E3" subjects_affected="30" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="24" subjects_at_risk="105"/>
                <counts group_id="E6" subjects_affected="23" subjects_at_risk="112"/>
              </event>
              <event>
                <sub_title>Confusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="93"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="104"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="109"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="87"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="93"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="106"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="110"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="92"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="111"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="104"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="106"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="111"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Andrew Chang, MD, MS</name_or_title>
      <organization>Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center</organization>
      <phone>718-920-6626</phone>
      <email>achang3@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

